Neoadjuvant therapies are drug treatments breast cancer patients receive before surgery. These treatments can help shrink tumors and make breast surgery easier for the patient and surgeon, according to Harold Burstein, MD, PhD, a breast cancer specialist in the Susan F. Smith Center for Women’s Cancers at Dana-Farber.
Neoadjuvant therapy may include chemotherapy or anti-estrogen treatments such as tamoxifen. Neoadjuvant therapy is sometimes also called upfront, preoperative, or induction therapy.
Learn more about neoadjuvant therapy in the video below:
Click here to learn more about aromatase inhibitors and tamoxifen, two other drugs used to treat breast cancer.